FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015127576> ?p ?o ?g. }

• W2015127576 endingPage "32" @default.
• W2015127576 startingPage "26" @default.
• W2015127576 abstract "Despite considerable progress in immunosuppressive therapy, the incidence and severity of transplant vasculopathy (TVP) after cardiac transplantation have not declined. The renin-angiotensin system (RAS) plays a pivotal role in the proliferation of vascular smooth muscle cells (VSMCs) contributing to TVP. We compared the effects of an angiotensin-II blocker, losartan (AT(1) blocker), and an angiotensin-converting enzyme (ACE) inhibitor, enalapril, on the incidence of diseased vessels and the severity of experimental TVP in the Lewis-to-Fischer rat heterotopic heart transplantation model. Recipients were randomly divided into six groups, group 1: no therapy, group 2: 3 mg/kg per day cyclosporine (CyA) s.c., group 3: CyA and 10 mg/kg per day losartan p.o., group 4: CyA and 40 mg/kg per day enalapril p.o., and groups 5 and 6: as groups 3 and 4, but additionally pre-treated with losartan or enalapril 7 days prior to transplantation. Eighty days after grafting, we assessed the incidence and severity of TVP, expressed as percentage of diseased vessels and mean vessel occlusion (MVO), by digitizing morphometry. CyA and CyA/enalapril post-treatment significantly reduced MVO, compared with controls, but not the incidence. Additional reduction of MVO was achieved in CyA/enalapril pre-treatment and both CyA/losartan pre- and post-treatment groups when compared with CyA and untreated controls. However, only losartan post-treatment in combination with CyA reduced both incidence and MVO. Our results validate the important role of the RAS in neointimal proliferation after cardiac transplantation. Losartan appears to be superior to enalapril in preventing TVP after experimental cardiac transplantation. Therefore, AT(1) blockade with losartan might be a therapeutic option for the prevention of TVP in human heart recipients." @default.
• W2015127576 created "2016-06-24" @default.
• W2015127576 creator A5008426400 @default.
• W2015127576 creator A5033250422 @default.
• W2015127576 creator A5070080587 @default.
• W2015127576 creator A5083907006 @default.
• W2015127576 date "2003-01-01" @default.
• W2015127576 modified "2023-10-03" @default.
• W2015127576 title "Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy." @default.
• W2015127576 cites W1027728090 @default.
• W2015127576 cites W112657386 @default.
• W2015127576 cites W152620150 @default.
• W2015127576 cites W1553215445 @default.
• W2015127576 cites W1630718235 @default.
• W2015127576 cites W1780180651 @default.
• W2015127576 cites W1974041165 @default.
• W2015127576 cites W1982261092 @default.
• W2015127576 cites W1988294661 @default.
• W2015127576 cites W1988915450 @default.
• W2015127576 cites W1991631571 @default.
• W2015127576 cites W1992351338 @default.
• W2015127576 cites W1997093700 @default.
• W2015127576 cites W2004327312 @default.
• W2015127576 cites W2032546808 @default.
• W2015127576 cites W2047789109 @default.
• W2015127576 cites W2052879846 @default.
• W2015127576 cites W2054263413 @default.
• W2015127576 cites W2071983732 @default.
• W2015127576 cites W2086668249 @default.
• W2015127576 cites W2087375731 @default.
• W2015127576 cites W2106151825 @default.
• W2015127576 cites W2106649681 @default.
• W2015127576 cites W2107528190 @default.
• W2015127576 cites W2108072067 @default.
• W2015127576 cites W2113012431 @default.
• W2015127576 cites W2113125336 @default.
• W2015127576 cites W2134958970 @default.
• W2015127576 cites W2137252848 @default.
• W2015127576 cites W2137570167 @default.
• W2015127576 cites W2159045140 @default.
• W2015127576 cites W2168461091 @default.
• W2015127576 cites W2168800815 @default.
• W2015127576 cites W2212747205 @default.
• W2015127576 cites W2223214578 @default.
• W2015127576 cites W2315754377 @default.
• W2015127576 cites W2336189734 @default.
• W2015127576 cites W2345324892 @default.
• W2015127576 cites W2418766746 @default.
• W2015127576 cites W93919072 @default.
• W2015127576 doi "https://doi.org/10.1007/s00147-002-0506-x" @default.
• W2015127576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12545338" @default.
• W2015127576 hasPublicationYear "2003" @default.
• W2015127576 type Work @default.
• W2015127576 sameAs 2015127576 @default.
• W2015127576 citedByCount "4" @default.
• W2015127576 crossrefType "journal-article" @default.
• W2015127576 hasAuthorship W2015127576A5008426400 @default.
• W2015127576 hasAuthorship W2015127576A5033250422 @default.
• W2015127576 hasAuthorship W2015127576A5070080587 @default.
• W2015127576 hasAuthorship W2015127576A5083907006 @default.
• W2015127576 hasConcept C126322002 @default.
• W2015127576 hasConcept C126894567 @default.
• W2015127576 hasConcept C134018914 @default.
• W2015127576 hasConcept C164705383 @default.
• W2015127576 hasConcept C170493617 @default.
• W2015127576 hasConcept C27016395 @default.
• W2015127576 hasConcept C2775940317 @default.
• W2015127576 hasConcept C2778849806 @default.
• W2015127576 hasConcept C2779611605 @default.
• W2015127576 hasConcept C2780288358 @default.
• W2015127576 hasConcept C2908929049 @default.
• W2015127576 hasConcept C2911091166 @default.
• W2015127576 hasConcept C500558357 @default.
• W2015127576 hasConcept C71924100 @default.
• W2015127576 hasConcept C84393581 @default.
• W2015127576 hasConcept C90924648 @default.
• W2015127576 hasConceptScore W2015127576C126322002 @default.
• W2015127576 hasConceptScore W2015127576C126894567 @default.
• W2015127576 hasConceptScore W2015127576C134018914 @default.
• W2015127576 hasConceptScore W2015127576C164705383 @default.
• W2015127576 hasConceptScore W2015127576C170493617 @default.
• W2015127576 hasConceptScore W2015127576C27016395 @default.
• W2015127576 hasConceptScore W2015127576C2775940317 @default.
• W2015127576 hasConceptScore W2015127576C2778849806 @default.
• W2015127576 hasConceptScore W2015127576C2779611605 @default.
• W2015127576 hasConceptScore W2015127576C2780288358 @default.
• W2015127576 hasConceptScore W2015127576C2908929049 @default.
• W2015127576 hasConceptScore W2015127576C2911091166 @default.
• W2015127576 hasConceptScore W2015127576C500558357 @default.
• W2015127576 hasConceptScore W2015127576C71924100 @default.
• W2015127576 hasConceptScore W2015127576C84393581 @default.
• W2015127576 hasConceptScore W2015127576C90924648 @default.
• W2015127576 hasIssue "1" @default.
• W2015127576 hasLocation W20151275761 @default.
• W2015127576 hasOpenAccess W2015127576 @default.
• W2015127576 hasPrimaryLocation W20151275761 @default.
• W2015127576 hasRelatedWork W2015127576 @default.
• W2015127576 hasRelatedWork W2045487939 @default.

• next